Ropes & Gray represented CStone Pharmaceuticals in the transaction. CStone Pharmaceuticals formed a global strategic partnership with biotech EQRx to out-license two late-stage immune checkpoint inhibitor…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
